Hydroxyapatite Chromatography for Antibody Aggregate Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protein purification methods, such as ion exchange and hydrophobic interaction chromatography, often fail to effectively remove high molecular weight aggregates from antibody preparations without damaging the proteins or causing contamination, and hydroxyapatite chromatography has limitations in achieving a sufficiently pure product.
Innovation Solution
A novel hydroxyapatite chromatography method using a buffer with 1 to 20 mM sodium phosphate and 0.2 to 2.5 M NaCl at pH 6.4 to 7.6 for elution, allowing for the selective removal of high molecular weight aggregates from antibody preparations without compromising the biological activity of the antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If ion exchange chromatography is used to purify antibodies, then purification is achieved, but high molecular weight aggregates cannot be substantially removed
Solution Approach 1:
The invention changes the chemical parameters of the chromatography buffer by incorporating NaCl at concentrations of 0.15-1.0 M, which fundamentally alters the elution mechanism to enable selective removal of aggregates while preserving monomeric antibodies. This parameter change transforms the chromatography process from one that cannot separate aggregates to one that effectively removes them.
2Manufacturing precision
If hydrophobic interaction chromatography is used, then purification is achieved, but aggregate formation may be induced due to increased protein concentration
Solution Approach 1:
The invention changes the buffer composition parameters by using NaCl-based buffers instead of high organic solvent or high protein concentration conditions. This parameter change maintains purification effectiveness while eliminating the conditions that induce aggregate formation during hydrophobic interaction chromatography.
3Reliability
If size exclusion chromatography is used to remove aggregates, then aggregate removal is achieved, but significant dilution of the product occurs
Solution Approach 1:
The invention changes the chromatography mechanism from size-based separation to charge-based separation using NaCl gradient elution. This parameter change enables effective aggregate removal through differential binding to the ion exchange resin, eliminating the need for size exclusion chromatography that would cause product dilution.
4Manufacturing precision
If affinity chromatography is used, then purification is achieved, but leakage of ligands from the column can occur causing contamination
Solution Approach 1:
The invention replaces the affinity chromatography ligand system with an ion exchange resin system that uses charge-based interactions. This substitution eliminates ligand leakage and contamination while maintaining purification effectiveness through the NaCl gradient elution mechanism.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly reduces high molecular weight aggregates to less than 1% in the final antibody preparation, enhancing product purity and safety for therapeutic and diagnostic applications.
Implementation Method 1
The interactions between hydroxyapatite and proteins are complex and multi-mode. In one method of interaction, however, positively charged amino groups on proteins associate with the negatively charged P-sites and protein carboxyl groups interact by coordination complexation to C-sites.
Implementation Method 2
protein carboxyl groups interact by coordination complexation to C-sites
Implementation Method 3
A novel hydroxyapatite chromatography method using a buffer with 1 to 20 mM sodium phosphate and 0.2 to 2.5 M NaCl at pH 6.4 to 7.6 for elution, allowing for the selective removal of high molecular weight aggregates from antibody preparations
Data Source
AI summary
This invention relates to the application of hydroxyapatite chromatography to the purification of at least one antibody from a preparation containing high molecular weight aggregates. Further, this invention relates to an integration of ceramic hydroxyapatite chromatography into a combination chromatographic protocol for the removal of high molecular weight aggregates from an antibody preparation.